CA3147586C - Compositions et kits pour suspension d'omeprazole - Google Patents

Compositions et kits pour suspension d'omeprazole

Info

Publication number
CA3147586C
CA3147586C CA3147586A CA3147586A CA3147586C CA 3147586 C CA3147586 C CA 3147586C CA 3147586 A CA3147586 A CA 3147586A CA 3147586 A CA3147586 A CA 3147586A CA 3147586 C CA3147586 C CA 3147586C
Authority
CA
Canada
Prior art keywords
suspension
liquid diluent
sodium
poloxamer
omeprazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3147586A
Other languages
English (en)
Other versions
CA3147586A1 (fr
Inventor
Zeus Pendon
Steven Dinh
Original Assignee
Azurity Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/513,604 external-priority patent/US10751333B1/en
Application filed by Azurity Pharmaceuticals Inc filed Critical Azurity Pharmaceuticals Inc
Publication of CA3147586A1 publication Critical patent/CA3147586A1/fr
Application granted granted Critical
Publication of CA3147586C publication Critical patent/CA3147586C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des diluants liquides, des formulations et des kits de préparation de suspensions reconstituées d'un inhibiteur de la pompe à protons (par exemple, l'oméprazole). La présente invention concerne également des formulations de diluants liquides qui n'ont pas tendance à la formation de gel après l'exposition à des cycles de congélation-décongélation.
CA3147586A 2019-07-16 2020-07-15 Compositions et kits pour suspension d'omeprazole Active CA3147586C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/513,604 US10751333B1 (en) 2019-07-16 2019-07-16 Compositions and kits for omeprazole suspension
US16/513,604 2019-07-16
PCT/US2020/042157 WO2021011669A1 (fr) 2019-07-16 2020-07-15 Compositions et kits pour suspension d'oméprazole

Publications (2)

Publication Number Publication Date
CA3147586A1 CA3147586A1 (fr) 2021-01-21
CA3147586C true CA3147586C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
US12329752B2 (en) Compositions and kits for omeprazole suspension
US11813253B2 (en) Composition and method for proton pump inhibitor suspension
US20260091116A1 (en) Compositions and kits for omeprazole suspension
JP6796132B2 (ja) 液体剤形中の薬学的活性化合物放出性多層微小粒子
US12458593B2 (en) Suspensions and diluents for metronidazole and baclofen
CA3147586C (fr) Compositions et kits pour suspension d'omeprazole
CN107427505A (zh) 用于抑制喹啉衍生物的苦味的方法
JP5148813B2 (ja) プロトンポンプ阻害剤の液体剤形
US20240173282A1 (en) Stable oral baclofen compositions
EP2558079B1 (fr) Composition sèche de ciprofloxacine pour suspension buvable
JP2012188383A (ja) ドネペジル塩酸塩の内用液剤
Sneineh Determination and Evaluation of stability of Extemporaneous Preparations
CN119730851A (zh) 依达拉奉口服制剂及其改进的制备方法